Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TROSPIUM CHLORIDE USP, with a corresponding US DMF Number 22673.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 17, 2023, and payment made on February 15, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II